Anthropic’s New AI Model Could Supercharge CrowdStrike’s Growth
Wolfe Research upgrades CrowdStrike to Outperform and sets a $450 price target.
Already have an account? Sign in.
Wolfe Research upgrades CrowdStrike to Outperform and sets a $450 price target.
Analyst sees approvable assets and places stock on Positive Catalyst Watch.
Shareholders get $49.75 per share, a 52% premium to the June 22 price.
Semtech stock fell sharply following its Analyst Day as the company’s long-term $3.2 billion revenue goal failed to satisfy the market’s elevated expectations.
Be the first to know when deals break, stocks move, or biotech headlines hit.